Fulcrum Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Fulcrum Therapeutics, Inc. reported Earnings Per Share Diluted of $1.18 (loss) per share for the year ending 2025.

  • Fulcrum Therapeutics, Inc. showed a decrease of -637.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Fulcrum Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), Fulcrum Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 48.5%.
  • Historical annual values: Fiscal year 2025: $1.18 (loss) per share | Fiscal year 2024: $0.16 (loss) per share | Fiscal year 2023: $1.59 (loss) per share | Fiscal year 2022: $2.44 (loss) per share | Fiscal year 2021: $2.29 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: